Figure 2From: Wnt3a expression is associated with MMP-9 expression in primary tumor and metastatic site in recurrent or stage IV colorectal cancer Overall survival according to β-catenin expression. β-catenin-expressing group in primary tumor showed poorer survival outcome than non-expressing group (18.4 vs. 42.9 months, p = 0.05).Back to article page